Moreover, a number of studies have shown that obesity and insulin resistance are accompanied by decreased adiponectin levels and that adiponectin replacement under experimental setting is able to diminish both insulin resistance and atherosclerosis. This evidence concerns the gene ADIPOQ and atherosclerosis.